6.
Viorst Gwadz M, Collins L, Cleland C, Leonard N, Wilton L, Gandhi M
. Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health. 2017; 17(1):383.
PMC: 5418718.
DOI: 10.1186/s12889-017-4279-7.
View
7.
Khawcharoenporn T, Kendrick S, Smith K
. HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic. AIDS Patient Care STDS. 2012; 26(4):222-33.
DOI: 10.1089/apc.2011.0202.
View
8.
Gallagher T, Link L, Ramos M, Bottger E, Aberg J, Daskalakis D
. Self-Perception of HIV Risk and Candidacy for Pre-Exposure Prophylaxis Among Men Who Have Sex with Men Testing for HIV at Commercial Sex Venues in New York City. LGBT Health. 2016; 1(3):218-24.
DOI: 10.1089/lgbt.2013.0046.
View
9.
Smith D, Mendoza M, Stryker J, Rose C
. PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015. PLoS One. 2016; 11(6):e0156592.
PMC: 4892482.
DOI: 10.1371/journal.pone.0156592.
View
10.
Cadmus-Bertram L, Solk P, Agnew M, Starikovsky J, Schmidt C, Morelli W
. A multi-site trial of an electronic health integrated physical activity promotion intervention in breast and endometrial cancers survivors: MyActivity study protocol. Contemp Clin Trials. 2023; 130:107187.
PMC: 10413251.
DOI: 10.1016/j.cct.2023.107187.
View
11.
Broder-Fingert S, Kuhn J, Sheldrick R, Chu A, Fortuna L, Jordan M
. Using the Multiphase Optimization Strategy (MOST) framework to test intervention delivery strategies: a study protocol. Trials. 2019; 20(1):728.
PMC: 6915979.
DOI: 10.1186/s13063-019-3853-y.
View
12.
Turner L, Roepke A, Wardell E, Teitelman A
. Do You PrEP? A Review of Primary Care Provider Knowledge of PrEP and Attitudes on Prescribing PrEP. J Assoc Nurses AIDS Care. 2017; 29(1):83-92.
PMC: 7653672.
DOI: 10.1016/j.jana.2017.11.002.
View
13.
Takvorian S, Ladage V, Wileyto E, Mace D, Beidas R, Shulman L
. Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology. JAMA Oncol. 2020; 6(7):1104-1106.
PMC: 7193524.
DOI: 10.1001/jamaoncol.2020.0746.
View
14.
Lockhart E, Turner D, Ficek J, Livingston T, Logan R, Marhefka S
. Understanding Technology Fit Among People with HIV Based on Intersections of Race, Sex, and Sexual Behavior: An Equitable Approach to Analyzing Differences Across Multiple Social Identities. AIDS Behav. 2021; 25(8):2618-2629.
PMC: 7982513.
DOI: 10.1007/s10461-021-03223-x.
View
15.
Pinto R, Berringer K, Melendez R, Mmeje O
. Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature. AIDS Behav. 2018; 22(11):3681-3691.
PMC: 6208917.
DOI: 10.1007/s10461-018-2184-4.
View
16.
Patel M, Day S, Halpern S, Hanson C, Martinez J, Honeywell Jr S
. Generic Medication Prescription Rates After Health System-Wide Redesign of Default Options Within the Electronic Health Record. JAMA Intern Med. 2016; 176(6):847-8.
PMC: 7240800.
DOI: 10.1001/jamainternmed.2016.1691.
View
17.
Arrington-Sanders R, Morgan A, Oidtman J, Qian I, Celentano D, Beyrer C
. A Medical Care Missed Opportunity: Preexposure Prophylaxis and Young Black Men Who Have Sex With Men. J Adolesc Health. 2016; 59(6):725-728.
PMC: 5123899.
DOI: 10.1016/j.jadohealth.2016.08.006.
View
18.
Vittinghoff E, Sen S, McCulloch C
. Sample size calculations for evaluating mediation. Stat Med. 2008; 28(4):541-57.
DOI: 10.1002/sim.3491.
View
19.
Chou R, Evans C, Hoverman A, Sun C, Dana T, Bougatsos C
. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019; 321(22):2214-2230.
DOI: 10.1001/jama.2019.2591.
View
20.
Bauerle Bass S, Kelly P, Brajuha J, Gutierrez-Mock L, Koester K, DAvanzo P
. Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication. BMC Public Health. 2022; 22(1):17.
PMC: 8740429.
DOI: 10.1186/s12889-021-12425-w.
View